Objective/Methods: Type II collagen is the dominating collagen in articular
cartilage. It is essential for the structural integrity and the biomechani
cal properties of cartilage. Using immunohistology and in situ hybridizatio
n we systematically analyzed the protein and mRNA-expression of type II col
lagen in cartilage/bone sections without any signs of osteoarthritis and os
teoarthritic samples with various degrees of osteoarthritis.
Results: In normal articular cartilage without any histologic signs of oste
oarthritis type II collagen was distributed homogeneously. An expression of
the type II collagen-mRNA was not detectable in any of these samples. In c
artilage sections with a roughening of the cartilage surface and a superfic
ial loss of the safranin O staining as early histologic signs of osteoarthr
itis the immunohistologic staining for type II collagen was reduced in the
deep cartilage zone. An expression of the type II collagen-mRNA was found i
n 19 of 35 preparations. This expression, however, was restricted to the mi
ddle and deep zone of cartilage. A good and reproducible correlation of the
specific gene and protein expression was found in samples with more severe
osteoarthritic lesions.
Conclusions: Detailed information on metabolic changes and the activation o
f chondrocytes in osteoarthritic cartilage are important to characterize ce
rtain stages of osteoarthritis and thus identify new prognostic factors. In
creasing knowledge of the factors regulating the matrix synthesis and degra
dation in cartilage will provide the basis for new disease modifying therap
ies in osteoarthritis.